Insurance broker NFP's corporate venturing vehicle was among the investors in a round that will accelerate commercialisation of Hound Labs' advanced breathalyser.
US-based cannabis breathalyser developer Hound Labs completed a $30m series D round backed by NFP Ventures, the corporate venturing arm of insurance broker and consultancy NFP, on Tuesday.
The round was led by cannabis science and technology-focused private equity fund Intrinsic Capital Partners, with participation from Main Street Advisors, Icon Ventures and Benchmark.
Founded in 2014, Hound Labs has devised a breathalyser test that can detect whether a user is intoxicated with alcohol or THC, one of the active ingredients…
